Benralizumab in Real Life

被引：9

作者：

Miralles Lopez, J. C. ^{[1
]}

Escudero Pastor, A., I ^{[1
]}

Carbonell Martinez, A. ^{[1
]}

Navarro Garrido, C. ^{[1
]}

Bonilla Pacheco, Y. ^{[1
]}

Petrik Petrik, Y. ^{[1
]}

机构：

[1] Hosp Gen Univ Reina Sofia, Avda Intendente Jorge Palacios 1, Murcia 30003, Spain

来源：

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 2021年 / 31卷 / 01期

关键词：

Severe asthma; Real life; Benralizumab; ANTIBODY;

D O I：

10.18176/jiaci.0599

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：87 / 88

页数：2

共 8 条

[1] Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Benralizumab in a Patient Who Did Not Respond to Omalizumab [J].

Bernal-Rubio, L. ;

de-la-Hoz Caballer, B. ;

Almonacid-Sanchez, C. ;

Gonzalez-de-Olano, D. .

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2020, 30 (05) :378-379

[2] Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial [J].

Bleecker, Eugene R. ;

FitzGerald, J. Mark ;

Chanez, Pascal ;

Papi, Alberto ;

Weinstein, Steven F. ;

Barker, Peter ;

Sproule, Stephanie ;

Gilmartin, Geoffrey ;

Aurivillius, Magnus ;

Werkstrom, Viktoria ;

Goldman, Mitchell .

LANCET, 2016, 388 (10056) :2115-2127

[3] Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial [J].

Busse, William W. ;

Bleecker, Eugene R. ;

FitzGerald, J. Mark ;

Ferguson, Gary T. ;

Barker, Peter ;

Sproule, Stephanie ;

Olsson, Richard F. ;

Martin, Ubaldo J. ;

Goldman, Mitchell .

LANCET RESPIRATORY MEDICINE, 2019, 7 (01) :46-59

[4]

FitzGerald JM, 2016, LANCET, V388, P2128, DOI [10.1016/s0140-6736(16)31322-8, 10.1016/S0140-6736(16)31322-8]

[5] Benralizumab - a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity - a novel approach for the treatment of asthma [J].

Ghazi, Aasia ;

Trikha, Anita ;

Calhoun, William J. .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (01) :113-118

[6] Benralizumab: A New Approach for the Treatment of Severe Eosinophilic Asthma [J].

Gonzalez I, Davila ;

Benitez F, Moreno ;

Quirce, S. .

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (02) :84-93

[7] Postbronchodilator lung function improvements with benralizumab for patients with severe asthma [J].

Mathur, Sameer K. ;

Modena, Brian D. ;

Coumou, Hanneke ;

Barker, Peter ;

Kreindler, James L. ;

Zangrilli, James G. .

ALLERGY, 2020, 75 (06) :1507-1510

[8] Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma [J].

Nair, Parameswaran ;

Wenzel, Sally ;

Rabe, Klaus F. ;

Bourdin, Arnaud ;

Lugogo, Njira L. ;

Kuna, Piotr ;

Barker, Peter ;

Sproule, Stephanie ;

Ponnarambil, Sandhia ;

Goldman, Mitchell .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (25) :2448-2458

← 1 →